After reading the 177 pages of “Final Rule for Clinical Trails Registration and Results Information” (and re-reading it), can you honestly say:
You are certain you’re submitting everything it calls for?
You are in compliance with all required timelines?
You understand what changes under the final regulations, and what remains the same?
ClinicalTrials.gov: Mastering New Reporting Rules parses out the rules provisions, explaining who must report what — what information they must submit — what deadlines are — and what could happen if they miss the mark. You’ll get clear explanations of:
What has changed with enactment of the final rule
Best practices in complying with US clinical trial disclosure requirements
The four elements of an “applicable drug clinical trial,” according to the FDA
The enforcement landscape for ClinicalTrials.gov — what can the FDA do regarding noncompliance and when could enforcement start
How to decipher the ClinicalTrials.gov “voluntary submissions” provisions
How to navigate the provisions for “delayed submission” of results to ClinicalTrials.gov
ClinicalTrials.gov: Mastering New Reporting Rules provides you with the information you need to revamp your data submission programs to meet the new requirements.
Global Clinical Safety and Pharmacovigilance Officers
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Online Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.